Theravance Biopharma, Inc. (NASDAQ:TBPH) Q1 2023 Earnings Call Transcript May 8, 2023
Theravance Biopharma, Inc. misses on earnings expectations. Reported EPS is $-0.35 EPS, expectations were $-0.26.
Operator: Ladies and gentlemen, good afternoon. I’d like to welcome everyone to the Theravance Biopharma First Quarter 2023 Conference Call. [Operator Instructions] Also, today’s conference call is being recorded. And now I’d like to turn the call over to Rick Winningham, Chief Executive...
